Clear cell cancer of the uterine corpus: The association of clinicopathologic parameters and treatment on disease progression

Journal of Oncology

Volumn , Issue , 2011, Pages

  Varughese, Joyce ^a   Hui, Pei ^a   Lu, Lingeng ^b   Yu, Herbert ^b   Schwartz, Peter E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL; TOPOTECAN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; TREATMENT OUTCOME; UTERUS CANCER; VAGINA;

EID: 84855608438     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2011/628084     Document Type: Article

References (21)

1. Jemal A., Siegel R., Xu J., Ward E., Cancer statistics, 2010 CA: A Cancer Journal for Clinicians 2010 60 5 277 300
2. Mendivil A., Schuler K. M., Gehrig P. A., Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes Cancer Control 2009 16 1 46 52
3. Gadducci A., Cosio S., Spirito N., Cionini L., Clear cell carcinoma of the endometrium: a biological and clinical enigma Anticancer Research 2010 30 4 1327 1334
4. Olawaiye A. B., Boruta D. M., Management of women with clear cell endometrial cancer: a Society of Gynecologic Oncology (SGO) review Gynecologic Oncology 2009 113 2 277 283
5. Boren T. P., Miller D. S., Should all patients with serous and clear cell endometrial carcinoma receive adjuvant chemotherapy? Women's Health 2010 6 6 789 795
6. Creasman W. T., Kohler M. F., Odicino F., Maisonneuve P., Boyle P., Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium Gynecologic Oncology 2004 95 3 593 596 (Pubitemid 39610410)
7. Thomas M., Mariani A., Wright J. D., Madarek E. O. S., Powell M. A., Mutch D. G., Podratz K. C., Dowdy S. C., Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review Gynecologic Oncology 2008 108 2 293 297
8. Zorn K. K., Bonome T., Gangi L., Chandramouli G. V. R., Awtrey C. S., Gardner G. J., Barrett J. C., Boyd J., Birrer M. J., Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer Clinical Cancer Research 2005 11 18 6422 6430 (Pubitemid 41338978)
9. Risinger J. I., Maxwell G. L., Chandramouli G. V. R., Jazaeri A., Aprelikova O., Patterson T., Berchuck A., Barrett J. C., Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer Cancer Research 2003 63 1 6 11 (Pubitemid 36070410)
10. Abeler V. M., Kjorstad K. E., Clear cell carcinoma of the endometrium: a histopathological and clinical study of 97 cases Gynecologic Oncology 1991 40 3 207 217
11. Vandenput I., Vanhove T., Calster B. V., Gorp T. V., Moerman P., Verbist G., Vergote I., Amant F., The use of lymph vessel markers to predict endometrial cancer outcome International Journal of Gynecological Cancer 2010 20 3 363 367
12. Rauh-Hain J. A., Growdon W. B., Schorge J. O., Goodman A. K., Boruta D. M., McCann C., Horowitz N. S., Del Carmen M. G., Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma Gynecologic Oncology 2010 119 2 299 304
13. McMeekin D. S., Filiaci V. L., Thigpen J. T., Gallion H. H., Fleming G. F., Rodgers W. H., The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study Gynecologic Oncology 2007 106 1 16 22 (Pubitemid 46898605)
14. Sovak M. A., Hensley M. L., Dupont J., Ishill N., Alektiar K. M., Abu-Rustum N., Barakat R., Chi D. S., Sabbatini P., Spriggs D. R., Aghajanian C., Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: a retrospective study Gynecologic Oncology 2006 103 2 451 457 (Pubitemid 44740097)
15. Pignata S., Scambia G., Pisano C., Breda E., Di Maio M., Greggi S., Ferrandina G., Lorusso D., Zagonel V., Febbraro A., Riva N., De Rosa V., Gallo C., Perrone F., A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group British Journal of Cancer 2007 96 11 1639 1643 (Pubitemid 46847208)
16. Kwon J. S., Abrams J., Sugimoto A., Carey M. S., Is adjuvant therapy necessary for stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging? International Journal of Gynecological Cancer 2008 18 4 820 824 (Pubitemid 352020171)
17. Curtis R., Ron E., Hankey B., Hoover B., Curtis R. E., Freedman D. M., Ron E., New malignancies following breast cancer New Malignancies Among Cancer Survivors: SEER Cancer Registries 19732000 2006 Bethesda, Md, USA National Cancer Institute 181 205
18. Liang S. X., Pearl M., Liang S., Xiang L., Jia L., Yang B., Fadare O., Schwartz P. E., Chambers S. K., Kong B., Zheng W., Personal history of breast cancer as a significant risk factor for endometrial serous carcinoma in women aged 55 years old or younger International Journal of Cancer 2011 128 4 763 770
19. Carcangiu M. L., Radice P., Casalini P., Bertario L., Merola M., Sala P., Lynch syndrome-related endometrial carcinomas show a high frequency of nonendometrioid types and of high FIGO grade endometrioid types International Journal of Surgical Pathology 2010 18 1 21 26
20. Lu K. H., Dinh M., Kohlmann W., Watson P., Green J., Syngal S., Bandipalliam P., Chen L. M., Alien B., Conrad P., Terdiman J., Sun C., Daniels M., Burke T., Gershenson D. M., Lynch H., Lynch P., Broaddus R. R., Gynecologic cancer as a sentinel cancer for women with hereditary nonpolyposis colorectal cancer syndrome Obstetrics Gynecology 2005 105 3 569 574 (Pubitemid 40271224)
21. Kelly M. G., O'Malley D. M., Hui P., McAlpine J., Yu H., Rutherford T. J., Azodi M., Schwartz P. E., Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy Gynecologic Oncology 2005 98 3 353 359 (Pubitemid 41169144)